Newsfeeds Archive - Spark Newswire

3 minute read

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge

December 19, 3:24 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The S&P 500 also rose, gaining, 0.45% to 4,762.12.

BCAN

3 minute read

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

December 19, 2:34 PM

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.

AFRM

3 minute read

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results

By Avi Kapoor

December 19, 1:54 PM

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also rose, gaining, 0.38% to 4,758.55.

BCAN

1 minute read

Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?

By Vandana Singh

December 19, 11:36 AM

Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the

AZN

3 minute read

US Stocks Higher; Accenture Issues Weak Sales Outlook

By Avi Kapoor

December 19, 10:42 AM

U.S. stocks traded higher this morning, with the Dow Jones index gaining around more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.17% to 37,369.84 while the NASDAQ rose 0.25% to 14,941.77. The S&P 500 also rose, gaining, 0.17% to 4,748.81.

ACN

25 minute read

Earnings

Earnings Scheduled For November 7, 2023

By Benzinga Insights

November 7, 7:34 AM

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

ABUS

2 minute read

Compugen To Present New Data At SITC 2023 Suggesting Leading Edge Of Anti-IL18 Binding Protein Antibody, COM503, In Treating Cancer

By Benzinga Newsdesk

October 31, 9:20 AM

COM503, a potential first-in-class, high affinity anti-IL18 binding protein antibody frees endogenous IL-18 to inhibit cancer growthAnti-IL-18BP antibody immune modulation is confined to the tumor site expected to have a

CGEN

1 minute read

Compugen To Present New Clinical And Pre-Clinical Data In Multiple Presentations At SITC 2023

By Benzinga Newsdesk

September 27, 9:09 AM

Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced, it will present new clinical and pre-clinical data

CGEN

1 minute read